The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
Open accessAbstract
Introduction: Our purpose in conducting this study was to determine whether administration of high-dose tranexamic acid (TA) at the time of diagnosis of postpartum haemorrhage (PPH) could reduce blood loss. Methods: This was a randomised, controlled, multicentred, open-label trial. Women with PPH >800 mL following vaginal delivery were randomly assigned to receive TA (loading dose 4 g over 1 hour, then infusion of 1 g/hour over 6 hours) or not. In both groups, packed red blood cells (PRBCs) and colloids could be used according to French guidelines. The use of additional procoagulant treatments was permitted only in cases involving intractable bleeding. The primary objective was to assess the efficacy of TA in the reduction of blood loss in women with PPH, and the secondary objectives were the effect of TA on PPH duration, anaemia, transfusion and the need for invasive procedures. Results: A total of 144 women fully completed the protocol (72 in each group). Blood loss between enrolment and 6 hours later was significantly lower in the TA group than in the control group (median, 173 mL; first to third quartiles, 59 to 377) than in controls (221 mL; first to third quartiles 105 to 564) ( P = 0.041). In the TA group, bleeding duration was shorter and progression to severe PPH and PRBC transfusion was less frequent than in controls ( P < 0.03). Invasive procedures were performed in four women in the TA group and in seven controls ( P = NS). PPH stopped after only uterotonics and PRBC transfusion in 93% of women in the TA group versus 79% of controls ( P = 0.016). Mild, transient adverse manifestations occurred more often in the TA group than in the control group ( P = 0.03). Conclusions: This study is the first to demonstrate that high-dose TA can reduce blood loss and maternal morbidity in women with PPH. Although the study was not adequately powered to address safety issues, the observed side effects were mild and transient. A larger international study is needed to investigate whether TA can decrease the need for invasive procedures and reduce maternal morbidity in women with PPH. Trial registration: Controlled Trials ISRCTN09968140 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rank transformations as a bridge between parametric and nonparametric statistics
Conover, W. J., & Iman, R. L. (1981) · The American Statistician · doi:10.1080/00031305.1981.10479327 · Cited by 3,922
Hogan, M. C., Foreman, K. J., Naghavi, M., Ahn, S. Y., Wang, M., Makela, S. M., Lopez, A. D., Lozano, R., & Murray, C. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60518-1 · Cited by 2,194
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Fergusson, D. A., Hébert, P. C., Mazer, C. D., Fremes, S., MacAdams, C., Murkin, J. M., Teoh, K., Duke, P. C., Arellano, R., Blajchman, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802395 · Cited by 1,152
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
CHARBIT, B., MANDELBROT, L., SAMAIN, E., BARON, G., HADDAOUI, B., KEITA, H., SIBONY, O., MAHIEU‐CAPUTO, D., HURTAUD‐ROUX, M. F., HUISSE, M. G., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02297.x · Cited by 762
Self-citationWaterstone, M., Murphy, J. D., Bewley, S., & Wolfe, C. (2001) · BMJ · doi:10.1136/bmj.322.7294.1089 · Cited by 552
Kagoma, Y. K., Crowther, M. A., Douketis, J., Bhandari, M., Eikelboom, J., & Lim, W. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2008.09.015 · Cited by 359
Karkouti, K., Beattie, W. S., Dattilo, K. M., McCluskey, S. A., Ghannam, M., Hamdy, A., Wijeysundera, D. N., Fedorko, L., & Yau, T. M. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00724.x · Cited by 338
Shakur, H., Elbourne, D., Gülmezoglu, M., Alfirevic, Z., Ronsmans, C., Allen, E., & Roberts, I. (2010) · Trials · doi:10.1186/1745-6215-11-40 · Cited by 332
Cited by
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Prevention and Management of Postpartum Haemorrhage: Green‐top Guideline No. 52
(2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14178 · Cited by 756
Tranexamic Acid: A Review of its Use in the Treatment of Hyperfibrinolysis
McCormack, P. L. (2012) · Drugs · doi:10.2165/11209070-000000000-00000 · Cited by 640
FIGO recommendations on the management of postpartum hemorrhage 2022
Escobar, M. F., Nassar, A. H., Theron, G., Barnea, E. R., Nicholson, W., Ramasauskaite, D., Lloyd, I., Chandraharan, E., Miller, S., Burke, T., et al. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14116 · Cited by 406
Treatment for primary postpartum haemorrhage
Mousa, H. A., Blum, J., Abou El Senoun, G., Shakur, H., & Alfirevic, Z. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003249.pub3 · Cited by 389
Metadata
- Authors
- Ducloy-Bouthors, A.-S., Jude, B., Duhamel, A., Broisin, F., Huissoud, C., Keita-Meyer, H., Mandelbrot, L., Tillouche, N., Fontaine, S., Le Goueff, F., Depret-Mosser, S., Vallet, B., The EXADELI Study Group, & Susen, S.
- Venue
- Critical Care
- Published
- 2011-04-15
- Volume
- 15
- Issue
- 2
- Pages
- R117-R117
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2161206101
- Cited by
- 314
- References
- 18
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. https://app.cochat.ai/papers/10.1186/cc10143
- The paper
- Ducloy-Bouthors, A.-S., Jude, B., Duhamel, A., Broisin, F., Huissoud, C., Keita-Meyer, H., Mandelbrot, L., Tillouche, N., Fontaine, S., Le Goueff, F., Depret-Mosser, S., Vallet, B., The EXADELI Study Group, & Susen, S. (2011). High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care. https://doi.org/10.1186/cc10143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.